DESIGN THERAPEUTICS INC shareholders Q1 2023

DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 100 filers reported holding DESIGN THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.

DESIGN THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
DEUTSCHE BANK AG\ 24,856$143,4190.00%
CITIGROUP INC 3,407$19,6580.00%
Clearstead Advisors, LLC 610$3,5200.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 230,347$1,329,1020.00%
GOLDMAN SACHS GROUP INC 300,624$1,734,6010.00%
MORGAN STANLEY 69,377$400,3050.00%
ASSETMARK, INC 1,658$9,5670.00%
AMALGAMATED BANK 3,506$200.00%
BARCLAYS PLC 17,217$990.00%
Zurcher Kantonalbank (Zurich Cantonalbank) 1$60.00%
Bank of New York Mellon Corp 124,053$715,7860.00%
Citadel Advisors 6,100$35,1970.00%
Citadel Advisors 8,600$49,6220.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 304,069$1,754,4780.00%
JPMORGAN CHASE & CO 25,956$150,0000.00%
SIGNATUREFD, LLC 1,349$7,7840.00%
Mitsubishi UFJ Asset Management Co., Ltd. 19,306$111,3960.00%
Daiwa Securities Group Inc. 162$10.00%
SIMPLEX TRADING, LLC 537$30.00%
Covestor Ltd 8$00.00%
External links

This page lists DESIGN THERAPEUTICS INC's shareholders in Q1 2023. To view DESIGN THERAPEUTICS INC's shareholder history, click here.